Patents by Inventor Venkat Rao

Venkat Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
    Publication number: 20190048033
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an ether (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Application
    Filed: October 18, 2018
    Publication date: February 14, 2019
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Venkat Rao Gadhachanda, Godwin Pais, Akihiro Hashimoto, Qiuping Wang, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash S. Phadke
  • ERROR CONCEALMENT IN VIRTUAL REALITY SYSTEM
    Publication number: 20190037244
    Abstract: Example techniques are described for image processing. Processing circuitry may warp image content of a previous frame based on pose information of a device when the device requested image content information of the previous frame and pose information of the device when the device requested image content information of a current frame to generate warped image content, and blend image content from the warped image content with image content of the current frame to generate an error concealed frame. A display screen may display image content based on the error concealed frame.
    Type: Application
    Filed: July 31, 2017
    Publication date: January 31, 2019
    Inventors: Vinay Melkote Krishnaprasad, Pawan Kumar Baheti, Ajit Venkat Rao
  • COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
    Publication number: 20190031692
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 31, 2019
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Avinash S. Phadke, Xiangzhu Wang, Dawei Chen, Akihiro Hashimoto, Venkat Rao Gadhachanda, Godwin Pais, Qiuping Wang, Atul Agarwal, Milind Deshpande
  • Amino compounds for treatment of complement mediated disorders
    Patent number: 10189869
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof, wherein R12 or R13 on the A group is an amino substituent (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: January 29, 2019
    Assignee: Achillion Pharmaceuticals, Inc.
    Inventors: Venkat Rao Gadhachanda, Akihiro Hashimoto, Godwin Pais, Qiuping Wang, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Jason Allan Wiles, Avinash S. Phadke
  • ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
    Publication number: 20190023729
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Application
    Filed: September 24, 2018
    Publication date: January 24, 2019
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Venkat Rao Gadhachanda, Qiuping Wang, Godwin Pais, Akihiro Hashimoto, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash S. Phadke
  • STABILIZATION AND ROLLING SHUTTER CORRECTION FOR OMNIDIRECTIONAL IMAGE CONTENT
    Publication number: 20190020802
    Abstract: Techniques are described for addressing rolling shutter delay and in some cases rolling shutter delay and stabilization. Processing circuits may receive image content in overlapping portions of images, and may adjust the image content until there is overlap in the overlapping portions. Processing circuits may also receive information of deviation of the device from a common reference. Based on the overlapping image content, the deviation of the device from the common reference, and image content in non-overlapping portions, the processing circuits may determine mapping of coordinates to a rectangular mesh for generating an equirectangular image.
    Type: Application
    Filed: July 13, 2017
    Publication date: January 17, 2019
    Inventors: Vinay Melkote Krishnaprasad, Pushkar Gorur Sheshagiri, Pawan Kumar Baheti, Ajit Deepak Gupte, Ajit Venkat Rao
  • ASYNCHRONOUS TIME WARP WITH DEPTH DATA
    Publication number: 20190012826
    Abstract: A wearable display device is described that is connected to a host device. The wearable display device includes one or more sensors configured to generate eye pose data indicating a user's field of view, one or more displays, and one or more processors. The one or more processors are configured to output a representation of the eye pose data to the host device and extract one or more depth values for a rendered frame from depth data output by the host device. The rendered frame is generated using the eye pose data. The one or more processors are further configured to modify one or more pixel values of the rendered frame using the one or more depth values to generate a warped rendered frame and output, for display at the one or more displays, the warped rendered frame.
    Type: Application
    Filed: July 5, 2017
    Publication date: January 10, 2019
    Inventors: Vinay Melkote Krishnaprasad, Sudipto Banerjee, Pawan Kumar Baheti, Ajit Venkat Rao
  • Cooling method for planar electrical power transformer
    Patent number: 10147531
    Abstract: The present disclosure includes an electrical power transformer that may include a core and a conductor pack. A conductor pack may include a conducting layer disposed around a portion of the core, a first planar insulating layer disposed on a first side of the conducting layer, and a second planar insulating layer disposed on a second side of the conducting layer. A cooling member may be disposed adjacent to the conductor pack. A method of manufacturing an electrical power transformer may include providing a core and providing a plurality of planar conductor packs. The planar conductor packs including a plurality of planar conducting layers and a plurality of planar insulating layers. The method may include inserting a cooling member between insulating layers of adjacent ones of the plurality of planar conductor packs.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: December 4, 2018
    Assignee: Lear Corporation
    Inventors: Rutunj Rai, Venkat Rao Yalamanchili, Parminder Brar, Michael Scott Duco
  • Amide compounds for treatment of medical disorders
    Patent number: 10138225
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an amide substituent (R32) are provided. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein are capable of reducing the excessive activation of complement.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: November 27, 2018
    Assignee: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Avinash S. Phadke, Milind Deshpande, Atul Agarwal, Dawei Chen, Venkat Rao Gadhachanda, Akihiro Hashimoto, Godwin Pais, Qiuping Wang, Xiangzhu Wang
  • ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
    Publication number: 20180305375
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 25, 2018
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Avinash S. Phadke, Milind Deshpande, Atul Agarwal, Dawei Chen, Venkat Rao Gadhachanda, Akihiro Hashimoto, Godwin Pais, Qiuping Wang, Xiangzhu Wang
  • Ether compounds for treatment of complement mediated disorders
    Patent number: 10106563
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an ether (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: October 23, 2018
    Assignee: Achillion Pharmaecuticals, Inc.
    Inventors: Jason Allan Wiles, Venkat Rao Gadhachanda, Godwin Pais, Akihiro Hashimoto, Qiuping Wang, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash S. Phadke
  • Alkyne Compounds for Treatment of Complement Mediated Disorders
    Publication number: 20180298043
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof, wherein R12 or R13 on the A group is an alkyne (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Application
    Filed: June 12, 2018
    Publication date: October 18, 2018
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Godwin Pais, Akihiro Hashimoto, Venkat Rao Gadhachanda, Qiuping Wang, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash S. Phadke
  • Phosphonate compounds for treatment of complement mediated disorders
    Patent number: 10100072
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is a phosphonate (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: October 16, 2018
    Assignee: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Akihiro Hashimoto, Venkat Rao Gadhachanda, Godwin Pais, Qiuping Wang, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash Phadke
  • ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
    Publication number: 20180291046
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof, wherein R12 or R13 on the A group is an alkyne (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Application
    Filed: June 12, 2018
    Publication date: October 11, 2018
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Godwin Pais, Akihiro Hashimoto, Venkat Rao Gadhachanda, Qiuping Wang, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash S. Phadke
  • ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
    Publication number: 20180291047
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof, wherein R12 or R13 on the A group is an alkyne (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Application
    Filed: June 12, 2018
    Publication date: October 11, 2018
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Godwin Pais, Akihiro Hashimoto, Venkat Rao Gadhachanda, Qiuping Wang, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash S. Phadke
  • Compounds for the treatment of medical disorders
    Patent number: 10092584
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduce the excessive activation of complement.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: October 9, 2018
    Assignee: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Avinash S. Phadke, Milind Deshpande, Atul Agarwal, Dawei Chen, Venkat Rao Gadhachanda, Akihiro Hashimoto, Godwin Pais, Qiuping Wang, Xiangzhu Wang
  • Compounds for treatment of complement mediated disorders
    Patent number: 10087203
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: October 2, 2018
    Assignee: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Avinash S. Phadke, Xiangzhu Wang, Dawei Chen, Akihiro Hashimoto, Venkat Rao Gadhachanda, Godwin Pais, Qiuping Wang, Atul Agarwal, Milind Deshpande
  • Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
    Patent number: 10081645
    Abstract: Compounds, methods of use, and processes for making inhibitors of complement factor D comprising formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: September 25, 2018
    Assignee: Achillion Pharmaceuticals, Inc.
    Inventors: Jason Allan Wiles, Venkat Rao Gadhachanda, Qiuping Wang, Godwin Pais, Akihiro Hashimoto, Dawei Chen, Xiangzhu Wang, Atul Agarwal, Milind Deshpande, Avinash S. Phadke
  • SYSTEMS AND METHODS FOR CONTENT-ADAPTIVE IMAGE STITCHING
    Publication number: 20180253875
    Abstract: A method for stitching images by an electronic device is described. The method includes obtaining at least two images. The method also includes selecting a stitching scheme from a set of stitching schemes based on one or more content measures of the at least two images. The set of stitching schemes includes a first stitching scheme, a second stitching scheme, and a third stitching scheme. The method further includes stitching the at least two images based on a selected stitching scheme.
    Type: Application
    Filed: March 2, 2017
    Publication date: September 6, 2018
    Inventors: Pushkar Gorur Sheshagiri, Chiranjib Choudhuri, Sudipto Banerjee, Ajit Deepak Gupte, Pawan Kumar Baheti, Ajit Venkat Rao
  • Intelligent inventory storage system
    Patent number: 10045636
    Abstract: An apparatus for storing and retrieving electronic components such as, but not limited to: capacitors; resistors; and integrated circuits. Components are stored based on single package single location in lockable racks in a transportable cart. Information for each stored component, such as its part number, location, and quantity is stored in the local electronic board and is shared via Wi-Fi to a network of PCs.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: August 14, 2018
    Assignee: INOVAXE CORPORATION
    Inventors: Bahman Khoshnood, David Charles Ocasio, Venkat Rao Yeeli, Michael David Adamson